Novartis plans the first human tests next year of a "smart" contact lens it is developing with Google designed to help restore the eye's natural autofocus.
"This project is progressing well," Novartis Chief Executive Joe Jimenez told Swiss newspaper Le Temps in an interview.
"I had said it would take about five years to see a product on the market," Jimenez told the paper. "The calendar is on track and we are already developing a technological lens prototype (that) should be tested on humans in 2016."
A Novartis spokesman told Reuters that Jimenez was referring to a smart lens for accommodative vision correction in people with presbyopia, or age-related long sightedness, who can no longer read without glasses.
Under an agreement signed with Google in 2014, Novartis is also developing smart contact lenses to help diabetics track their blood glucose levels.
Jimenez also discussed Novartis' efforts to test a novel pay-for-performance pricing model with some customers for its new heart failure drug Entresto.
Earlier this year, Novartis said it was pursuing a system under which customers would get the drug at a discount but then pay Novartis more if it cut the need for costly hospital visits.
Jimenez indicated the plan has encountered headwinds.
"In the United States, we proposed to insurers a differentiated price calculated according to length of stay," Jimenez said. "Few insurers entered in the field. They told us that the system was too complicated."
Novartis finally established the price at around $4,500 per year, he said.
The CEO, a former executive at Reddiwip-maker ConAgra Foods who joined Novartis in 2007, also said the company expects its generics business Sandoz "will always be large enough to be competitive worldwide" without joining a consolidation trend.
Israeli generics rival Teva agreed to buy Allergan's generics unit in July for more than $40 billion.
"There is no project on our side to participate in this consolidation trend because we cannot ensure this growth," Jimenez said.
Novartis, which owns a one-third voting stake in pharmaceuticals rival Roche, has trade agreements with Roche on two drugs and Jimenez said he can imagine research and development collaborations, as well.
"But the opportunity hasn't presented itself yet," he said.
Reuters
Sun Sep 06 2015
Under an agreement signed with Google in 2014, Novartis is also developing smart contact lenses to help diabetics track their blood glucose levels.
AWANI Ringkas: Malaysia kecewa AS veto, halang PBB iktiraf Palestin
Ikuti rangkuman berita utama yang menjadi tumpuan sepanjang hari di Astro AWANI menerusi AWANI Ringkas.
AWANI Ringkas: Perang Iran-Israel
Ikuti rangkuman berita utama yang menjadi tumpuan sepanjang hari di Astro AWANI menerusi AWANI Ringkas.
Buang beras, tepung di tapak pelupusan sampah, bekas MP tampil beri penjelasan
Tular satu rakaman yang memaparkan puluhan kampit beras, tepung dan sardin dibuang di tapak pelupusan sampah berdekatan laluan pintasan Rumpun Makmur, Kampung Gunung Senyum, Temerloh, Pahang.
Kes tangkapan lelaki Israel: 10 ditahan semula di bawah Sosma
Tiga terdiri suspek utama iaitu Avitan dan pasangan suami isteri telah dituduh di mahkamah pada minggu lalu, manakala lima lagi dibebaskan.
Wanita cedera diragut ketika tunggang motosikal ke tempat kerja
Mangsa dilapor alami kerugian kira-kira RM3,000 selepas kehilangan beg yang berisi telefon bimbit jenis iPhone 14, dokumen peribadi dan wang tunai RM114.
"OIC dah tak bermakna, tak berguna dalam meredakan ketegangan"
Pandangan dikongsi Prof Dr Salawati Mat Basir, Pakar undang-undang antarabangsa, Universiti Kebangsaan Malaysia (UKM).
Perkembangan konflik Iran-Israel
Bagi perinciannya kita bersama Prof. Dr. Mohd Roslan Mohd Nor, Ketua Jabatan Sejarah dan Tamdun Islam, Universiti Malaya, UM.
Program Madani Rakyat Zon Utara di Tapak Pesta Sungai Nibong 3-5 Mei
Program MADANI Rakyat 2024 Zon Utara akan diadakan di Tapak Pesta Sungai Nibong, Pulau Pinang selama tiga hari bermula 3 Mei ini.
Malaysia kecewa AS veto, halang PBB iktiraf negara Palestin
Pelaksanaan veto ke atas perkara penting dan signifikan itu telah menimbulkan persoalan terhadap keinginan sebenar Ahli UNSC.